Internal Medicine, Rheumatology · Gainesville, GA
NPI
1902914872
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
700 S Enota Dr NE
Gainesville, GA, 30501
Phone (770) 531-3711
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.3M
191,321 services
Medicare patients, 2024
729
Average age 74
Drug cost, 2024
$5.6M
5,477 prescriptions
Company payments, 2025
$3,607
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brent A Flickinger was code J3262 (injection, tocilizumab, 1 mg), 72,999 times for 33 patients. In total Brent A Flickinger billed 191,321 services in 82 codes, and Medicare paid $2.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 72,999 | 33 | $4.70 | $343K |
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 40,801 | 36 | $3.61 | $147K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 25,644 | 56 | $9.06 | $232K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 20,125 | 68 | $33.72 | $679K |
| J9312 Injection, rituximab, 10 mg | Office | 6,358 | 46 | $61.28 | $390K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 3,041 | 38 | $0.10 | $306 |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 2,300 | 12 | $24.06 | $55K |
| J0897 Injection, denosumab, 1 mg | Office | 1,622 | 27 | $19.46 | $32K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 1,399 | 38 | $0.22 | $314 |
| 36415 Venipuncture Blood Collection | Office | 836 | 422 | $8.60 | $7,192 |
| 99214 Office E&M - Established | Office | 821 | 422 | $88.52 | $73K |
| 96413 Chemotherapy Administration | Office | 654 | 220 | $93.84 | $61K |
| 80053 Clinical Chemistry | Office | 437 | 318 | $10.35 | $4,523 |
| 85025 Blood Count | Office | 424 | 306 | $7.61 | $3,227 |
| 86140 Clinical Chemistry | Office | 318 | 240 | $5.07 | $1,612 |
By year: 2022 $2.7M for 212,305 services; 2023 $2.3M for 194,086 services; 2024 $2.3M for 191,321 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 836 | 422 | $8.60 | $7,192 |
| 80053 Clinical Chemistry | 437 | 318 | $10.35 | $4,523 |
| 85025 Blood Count | 424 | 306 | $7.61 | $3,227 |
| 86140 Clinical Chemistry | 318 | 240 | $5.07 | $1,612 |
| 86160 Immunoassay | 118 | 53 | $11.76 | $1,388 |
| 85652 Clinical Chemistry | 107 | 95 | $2.65 | $284 |
| 83516 Immunoassay | 40 | 20 | $11.30 | $452 |
| 84550 Clinical Chemistry | 38 | 31 | $4.43 | $168 |
| 82306 Clinical Chemistry | 33 | 33 | $29.01 | $957 |
| 86480 Immunoassay | 24 | 24 | $60.74 | $1,458 |
Medicare prescription drug claims, 2024
In 2024, the drug Brent A Flickinger prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 793 prescriptions and refills. In total Brent A Flickinger wrote 5,477 Medicare prescriptions that cost $5.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 793 | 1,527 | 193 | $28K |
| Methotrexate Methotrexate Sodium | 694 | 1,260 | 178 | $14K |
| Prednisone Generic | 468 | 674 | 153 | $2,780 |
| Duloxetine Hcl Generic | 326 | 543 | 71 | $4,606 |
| Gabapentin Generic | 303 | 477 | 76 | $5,224 |
| Tramadol Hcl Generic | 272 | 287 | 53 | $1,838 |
| Leflunomide Generic | 204 | 391 | 63 | $9,095 |
| Allopurinol Generic | 153 | 289 | 35 | $1,344 |
| Tizanidine Hcl Generic | 141 | 181 | 38 | $704 |
| Orencia Clickject Abatacept | 107 | 116 | 14 | $690K |
| Sulfasalazine Dr Sulfasalazine | 87 | 142 | 22 | $4,486 |
| Pregabalin Generic | 82 | 124 | 23 | $2,800 |
| Meloxicam Generic | 76 | 83 | 18 | $215 |
| Mycophenolate Mofetil Generic | 69 | 123 | 17 | $8,779 |
| Enbrel Sureclick Etanercept | 67 | 79 | Under 11 | $576K |
Brand drugs: - claims; generic drugs: 4,586 claims; opioid claims: 307.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brent A Flickinger $3,607 ($3,607 in general payments such as food, travel and fees) from 24 companies. The largest payer was Abbvie Inc. with $1,217.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 66 | $1,217 |
| Novartis Pharmaceuticals Corporation NVS | 31 | $574 |
| Janssen Biotech, Inc. JNJ | 17 | $459 |
| Amgen Inc. AMGN | 20 | $358 |
| UCB, Inc. UCB.BR | 10 | $209 |
| Pfizer Inc. PFE | 8 | $160 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $79.87 |
| Radius Health, Inc. | 2 | $55.71 |
| Aurinia Pharma U.S., Inc. AUPH | 3 | $55.35 |
| Genzyme Corporation SNY | 2 | $54.16 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.